Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 51, 2019 - Issue 2: 50th Anniversary: Psychedelic Research Today
Submit an article Journal homepage
37,233
Views
44
CrossRef citations to date
0
Altmetric
Introduction

The Past and Future of Psychedelic Science: An Introduction to This Issue

Richard E. DoblinExecutive Director and Found, Multidisciplinary Association for Psychedelic Studies (MAPS), Santa Cruz, CA, USAView further author information
,
Merete ChristiansenExecutive Assistant, Multidisciplinary Association for Psychedelic Studies (MAPS), Santa Cruz, CA, USACorrespondence[email protected]
View further author information
,
Lisa JeromeClinical Research and Information Specialist, MAPS Public Benefit Corporation, Santa Cruz, CA, USAORCID Iconhttp://orcid.org/0000-0001-6209-8750View further author information
ORCID Icon &
Brad BurgeDirector of Strategic Communications, MAPS, Santa Cruz, CA, USAView further author information
Pages 93-97 | Received 02 Apr 2019, Accepted 09 Apr 2019, Published online: 27 May 2019

References

  • Baggott, M. J., K. J. Garrison, J. R. Coyle, G. P. Galloway, A. J. Barnes, M. A. Huestis, and J. E. Mendelson. 2019. Effects of the psychedelic amphetamine MDA (3,4-methylenedioxyamphetamine) in healthy volunteers. J Psychoactive Drugs 51(02):108–117.
  • Barone, W., J. Beck, M. Mitsunaga-Whitten, and P. Perl. 2019. Perceived benefits of MDMA-assisted psychotherapy beyond symptom reduction: qualitative follow-up study of a clinical trial for individuals with treatment-resistant PTSD. J Psychoactive Drugs 51 (02):199–208. doi:10.1080/02791072.2019.1580805.
  • Carhart-Harris, R. L., L. Roseman, M. Bolstridge, L. Demetriou, J. N. Pannekoek, M. B. Wall, M. Tanner, M. Kaelen, J. McGonigle, K. Murphy, et al. 2017. Psilocybin for treatment-resistant depression: FMRI-measured brain mechanisms. Sci Rep 7 (1):13187. doi:10.1038/s41598-017-13282-7.
  • Danforth, A. L. 2019. Embracing neurodiversity in psychedelic science: A mixed-methods inquiry into the MDMA experiences of autistic adults. J Psychoactive Drugs 51 (02):146–154. doi:10.1080/02791072.2019.1587116.
  • Dore, J., B. Turnipseed, S. Dwyer, A. Turnipseed, J. Andries, G. Ascani, C. Monnette, A. Huidekoper, N. Strauss, and P. Wolfson. 2019. Ketamine assisted psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy. J Psychoactive Drugs 51 (02):189–198. doi:10.1080/02791072.2019.1587556.
  • Dyck, E. 2019. Psychedelics and dying care: A historical look at the relationship between psychedelics and palliative care. J Psychoactive Drugs 51 (02):102–107. doi:10.1080/02791072.2019.1581308.
  • Fox, K., M. Girn, C. Parro, and K. Christoff. 2018. Functional neuroimaging of psychedelic experience: An overview of psychological and neural effects and their relevance to research on creativity, daydreaming, and dreaming. In The cambridge handbook of the neuroscience of creativity, ed. R. Jung and O. Vartanian, 92–113. Cambridge, UK: Cambridge University Press.
  • Griffiths, R. R., M. W. Johnson, M. A. Carducci, A. Umbricht, W. A. Richards, B. D. Richards, M. P. Cosimano, and M. A. Klinedinst. 2016. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 30 (12):1181–97. doi:10.1177/0269881116675513.
  • Hayley, S., and D. Litteljohn. 2013. Neuroplasticity and the next wave of antidepressant strategies. Front Cell Neurosci 7:218. doi:10.3389/fncel.2013.00218.
  • Mason, N. L., E. Mischler, M. V. Uthaug, and K. P. C. Kuypers. 2019. Sub-acute effects of psilocybin on empathy, creative thinking, and subjective well-being. J Psychoactive Drugs 51 (02):123–134. doi:10.1080/02791072.2019.1580804.
  • Nichols, D. E. 2016. Psychedelics. Pharmacol Rev 68 (2):264–355. doi:10.1124/pr.115.011478.
  • Ona, G., M. Kohek, T. Massaguer, A. Gomariz, D. F. Jimenez, R. G. Dos Santos, J. E. C. Hallak, M. A. Alcazar-Corcoles, and J. C. Bouso. 2019. Ayahuasca and public health: health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users. J Psychoactive Drugs 51 (02):135–145. doi:10.1080/02791072.2019.1567961.
  • Ross, S., A. Bossis, J. Guss, G. Agin-Liebes, T. Malone, B. Cohen, S. E. Mennenga, A. Belser, K. Kalliontzi, J. Babb, et al. 2016. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. J Psychopharmacol 30 (12):1165–80.
  • Smith, D. E. 2019. The role of the journal of psychedelic drugs in the evolution of psychedelic medicine. J Psychoactive Drugs 51 (02):98–101. doi:10.1080/02791072.2019.1589607.
  • Stolaroff, M. 2004. The Secret Chief Revealed: Conversations with a pioneer of the underground therapy movement. Sarasota FL: Multidisciplinary Association for Psychedelic Studies.
  • Wagner, A. C., M. C. Mithoefer, A. T. Mithoefer, and C. M. Monson. 2019. Combining cognitive-behavioral conjoint therapy for PTSD with 3,4-methylenedioxymethamphetamine (MDMA): A case example. J Psychoactive Drugs 51 (02):166–173. doi:10.1080/02791072.2019.1589028.
  • World Health Organization. 2017. WHO model list of essential medicines. https://apps.who.int/iris/bitstream/handle/10665/273826/EML-20-eng.pdf?ua=.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.